Suppr超能文献

乳腺癌发生和干性中EBF1/ETS2/KLF2-miR-126基因前馈环的鉴定

Identification of the EBF1/ETS2/KLF2-miR-126-Gene Feed-Forward Loop in Breast Carcinogenesis and Stemness.

作者信息

Gambacurta Alessandra, Tullio Valentina, Savini Isabella, Mauriello Alessandro, Catani Maria Valeria, Gasperi Valeria

机构信息

Department of Experimental Medicine, Tor Vergata University of Rome, 00133 Rome, Italy.

NAST Centre (Nanoscience & Nanotechnology & Innovative Instrumentation), 00133 Rome, Italy.

出版信息

Int J Mol Sci. 2025 Jan 2;26(1):328. doi: 10.3390/ijms26010328.

Abstract

MicroRNA (miR)-126 is frequently downregulated in malignancies, including breast cancer (BC). Despite its tumor-suppressive role, the mechanisms underlying miR-126 deregulation in BC remain elusive. Through silencing experiments, we identified Early B Cell Factor 1 (EBF1), ETS Proto-Oncogene 2 (ETS2), and Krüppel-Like Factor 2 (KLF2) as pivotal regulators of miR-126 expression. These transcription factors were found to be downregulated in BC due to epigenetic silencing or a "poised but not transcribed" promoter state, impairing miR-126 expression. Gene Ontology analysis of differentially expressed miR-126 target genes in the Cancer Genome Atlas: Breast Invasive Carcinoma (TCGA-BRCA) cohort revealed their involvement in cancer-related pathways, primarily signal transduction, chromatin remodeling/transcription, and differentiation/development. Furthermore, we defined interconnections among transcription factors, miR-126, and target genes, identifying a potential feed-forward loop (FFL) crucial in maintaining cellular identity and preventing the acquisition of stemness properties associated with cancer progression. Our findings propose that the dysregulation of the EBF1/ETS2/KLF2/miR-126 axis disrupts this FFL, promoting oncogenic transformation and progression in BC. This study provides new insights into the molecular mechanisms of miR-126 downregulation in BC and highlights potential targets for therapeutic intervention. Further research is warranted to clarify the role of this FFL in BC, and to identify novel therapeutic strategies aimed at modulating this network as a whole, rather than targeting individual signals, for cancer management.

摘要

微小RNA(miR)-126在包括乳腺癌(BC)在内的多种恶性肿瘤中经常下调。尽管其具有肿瘤抑制作用,但BC中miR-126失调的潜在机制仍不清楚。通过沉默实验,我们确定早期B细胞因子1(EBF1)、ETS原癌基因2(ETS2)和Krüppel样因子2(KLF2)是miR-126表达的关键调节因子。由于表观遗传沉默或“处于就绪但未转录”的启动子状态,这些转录因子在BC中被下调,从而损害了miR-126的表达。对癌症基因组图谱:乳腺浸润性癌(TCGA-BRCA)队列中差异表达的miR-126靶基因进行基因本体分析,发现它们参与了癌症相关途径,主要是信号转导、染色质重塑/转录以及分化/发育。此外,我们定义了转录因子、miR-126和靶基因之间的相互联系,确定了一个潜在的前馈环(FFL),它对于维持细胞特性和防止获得与癌症进展相关的干性特性至关重要。我们的研究结果表明,EBF1/ETS2/KLF2/miR-126轴的失调破坏了这个FFL,促进了BC中的致癌转化和进展。这项研究为BC中miR-126下调的分子机制提供了新的见解,并突出了治疗干预的潜在靶点。有必要进一步研究以阐明这个FFL在BC中的作用,并确定旨在整体调节这个网络而非针对单个信号的新型治疗策略,用于癌症管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/535d/11719960/434ed6921ac0/ijms-26-00328-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验